pegph20
Recombinant proteinexperimental
Clinical trial activity
14 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
8
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00834704)
Timeline
Indications
Mechanism of action
- Hyaluronate lyaseSupplementation
Hyaluronate lyase supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- pegpem
- pegph20
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03979066 | Phase 2 | Jul 31, 2019 | Columbia University, Genentech, Halozyme Therapeutics |
| NCT03634332 | Phase 2 | Sep 30, 2018 | Halozyme Therapeutics, Merck, Pancreatic Cancer Research Team, University of Washington |
| NCT03267940 | Phase 1 | Sep 12, 2017 | Halozyme Therapeutics |
| NCT03193190 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2017 | Roche |
| NCT02921022 | N/A | Oct 1, 2016 | Cornell University, Halozyme Therapeutics, Miami Cancer Institute |
| NCT02563548 | Phase 1 | Oct 1, 2015 | Halozyme Therapeutics |
| NCT02487277 | Phase 2 | Jul 1, 2015 | University of California, San Francisco |
| NCT02346370 | Phase 1 | Nov 30, 2014 | Halozyme Therapeutics |
| NCT02241187 | N/A | Sep 12, 2014 | Cold Spring Harbor Laboratory, Cornell University, Weizmann Institute of Science |
| NCT01959139 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2014 | Halozyme Therapeutics, HonorHealth Research Institute, National Cancer Institute (NCI), Southwest Oncology Group |
| NCT01839487 | Phase 2 | Apr 1, 2013 | Halozyme Therapeutics |
| NCT01453153 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2011 | Halozyme Therapeutics |
| NCT01170897 | Phase 1 | Jul 1, 2010 | Halozyme Therapeutics |
| NCT00834704 | Phase 1 | Feb 1, 2009 | Halozyme Therapeutics |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Halozyme Therapeutics | For profit | 11 | 7 | 3 | 2009 |
| Cornell University | Academic/Hospital | 2 | 2 | 1 | 2014 |
| Cold Spring Harbor Laboratory | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Genentech | For profit | 1 | 0 | 1 | 2019 |
| HonorHealth Research Institute | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Merck | For profit | 1 | 0 | 1 | 2018 |
| Miami Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2016 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2014 |
| Pancreatic Cancer Research Team | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Roche | For profit | 1 | 1 | 1 | 2017 |
| Southwest Oncology Group | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Weizmann Institute of Science | Academic/Hospital | 1 | 0 | 1 | 2014 |
15 organizations
Page 1 / 1